A Randomized, Double-blind, Placebo-controlled Study on Immunogenicity and Safety of MVA-BN (IMVAMUNE™) Smallpox Vaccine in Healthy Subjects
Clinical trial NCT00316524 · COMPLETED
Trial details
- NCT number
- NCT00316524
- Sponsor
- Bavarian Nordic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-04-01
- Primary completion
- 2007-02-01
- Enrollment
- 745
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.